The Breast Cancer Markers Panel is a group of blood tests (CA 15-3, CA 27.29, CEA) used to monitor treatment response and detect recurrence in patients already diagnosed with breast cancer.
The Breast Cancer Markers Panel is a set of blood tests that measure tumor markers associated with breast cancer, mainly CA 15-3, CA 27.29 and Carcinoembryonic Antigen (CEA). It is used to monitor treatment response and disease progression, not to screen for or diagnose breast cancer on its own.
This test is recommended to
- Monitor breast cancer treatment effectiveness
- Detect recurrence of breast cancer
- Evaluate disease progression
- Support ongoing cancer management
- Assist in clinical decision-making
Who is it for?
- Patients diagnosed with breast cancer requiring treatment monitoring
- Individuals undergoing chemotherapy, hormone therapy, targeted therapy or radiation therapy
- Patients requiring follow-up after breast cancer treatment
- Individuals suspected of having recurrent or metastatic breast cancer
FAQs
Do I need to fast before this test?
No, fasting is generally not required, but always follow your doctor's specific instructions.
Can this panel diagnose breast cancer?
No. It cannot diagnose breast cancer on its own and is not a screening test. Results are interpreted together with imaging, biopsy findings and clinical evaluation.